CVE-2026-21970Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).
Updated under an hour ago ()
Does this affect you?
It affects Oracle Corporation Oracle Life Sciences Central Designer. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
- CVSS
- 6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- oracle
- NVD analysis
- Analyzed
- Record last updated
- Jan 21, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Oracle Corporation Oracle Life Sciences Central Designer oracle:life_sciences_central_designer (from the name) | 7.0.1.0 | CNA record |
oracle life_sciences_central_designer oracle:life_sciences_central_designer | 7.0.1.0 | NVD |
References
- https://www.oracle.com/security-alerts/cpujan2026.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.